| Products | Training | Consulting | Seminar Series | About | Contact |
| Program and Project Management Solutions for: Gov. Agencies | Gov. Contractors | Commercial |
Like other industries in today’s business climate, the pharmaceutical industry is being asked to do more with less. Pharmaceutical companies face increasing pressure to research, develop and release new drugs to the marketplace while adhering to stricter deadlines, tightening budgets and stringent federal regulations. Compounding the problem is the fact that most drugs in the development pipeline never receive FDA approval. Early identification of those drugs unlikely to gain approval is absolutely essential in determining project resource allocation.To gain the maximum return on investment and excel in this highly volatile multi-project environment, pharmaceutical companies are turning to project portfolio management (PPM) methodology and tools. A sound PPM process enables pharmaceutical executives to obtain a clear view of the drug development pipeline in order to determine which drug projects should receive investment. Ultimately, PPM maximizes return on investment by ensuring current and future drug development projects are in alignment with the priorities, goals and objectives of the pharmaceutical organization.
Dekker offers a wide range of education and products that enable pharmaceutical companies to implement and maintain a disciplined PPM process. Our PPM solutions can help expedite project management, idea management, risk management, resource allocation and collaboration, enabling companies to convert promising drug product portfolios into profitable revenue streams.
For more information on Dekker University and the types of courses offered, please click here or call 1-800-4-DEKKER.
For more information on Dekker’s product solutions, please click here or call 1-800-4-DEKKER.
To learn more about the integration and compatibility of the Dekker Project Management Information System (PMIS), please click here or call 1-800-4-DEKKER.